Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Short Communication

A Genome-wide Association Study of Early-Onset Breast Cancer Identifies PFKM as a Novel Breast Cancer Gene and Supports a Common Genetic Spectrum for Breast Cancer at Any Age

Habibul Ahsan, Jerry Halpern, Muhammad G. Kibriya, Brandon L. Pierce, Lin Tong, Eric Gamazon, Valerie McGuire, Anna Felberg, Jianxin Shi, Farzana Jasmine, Shantanu Roy, Rachelle Brutus, Maria Argos, Stephanie Melkonian, Jenny Chang-Claude, Irene Andrulis, John L. Hopper, Esther M. John, Kathi Malone, Giske Ursin, Marilie D. Gammon, Duncan C. Thomas, Daniela Seminara, Graham Casey, Julia A. Knight, Melissa C. Southey, Graham G. Giles, Regina M. Santella, Eunjung Lee, David Conti, David Duggan, Steve Gallinger, Robert Haile, Mark Jenkins, Noralane M. Lindor, Polly Newcomb, Kyriaki Michailidou, Carmel Apicella, Daniel J. Park, Julian Peto, Olivia Fletcher, Isabel dos Santos Silva, Mark Lathrop, David J. Hunter, Stephen J. Chanock, Alfons Meindl, Rita K. Schmutzler, Bertram Müller-Myhsok, Magdalena Lochmann, Lars Beckmann, Rebecca Hein, Enes Makalic, Daniel F. Schmidt, Quang Minh Bui, Jennifer Stone, Dieter Flesch-Janys, Norbert Dahmen, Heli Nevanlinna, Kristiina Aittomäki, Carl Blomqvist, Per Hall, Kamila Czene, Astrid Irwanto, Jianjun Liu, Nazneen Rahman, Clare Turnbull, for the Familial Breast Cancer Study, Alison M. Dunning, Paul Pharoah, Quinten Waisfisz, Hanne Meijers-Heijboer, Andre G. Uitterlinden, Fernando Rivadeneira, Dan Nicolae, Douglas F. Easton, Nancy J. Cox and Alice S. Whittemore
Habibul Ahsan
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jerry Halpern
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Muhammad G. Kibriya
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brandon L. Pierce
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin Tong
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Gamazon
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valerie McGuire
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Felberg
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianxin Shi
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farzana Jasmine
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shantanu Roy
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachelle Brutus
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Argos
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie Melkonian
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jenny Chang-Claude
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irene Andrulis
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John L. Hopper
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esther M. John
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathi Malone
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giske Ursin
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marilie D. Gammon
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Duncan C. Thomas
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniela Seminara
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graham Casey
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia A. Knight
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melissa C. Southey
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graham G. Giles
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Regina M. Santella
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eunjung Lee
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Conti
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Duggan
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steve Gallinger
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Haile
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Jenkins
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noralane M. Lindor
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Polly Newcomb
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyriaki Michailidou
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carmel Apicella
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel J. Park
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julian Peto
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivia Fletcher
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabel dos Santos Silva
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Lathrop
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. Hunter
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen J. Chanock
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfons Meindl
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rita K. Schmutzler
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bertram Müller-Myhsok
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Magdalena Lochmann
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lars Beckmann
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca Hein
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Enes Makalic
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel F. Schmidt
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Quang Minh Bui
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Stone
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dieter Flesch-Janys
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norbert Dahmen
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heli Nevanlinna
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristiina Aittomäki
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carl Blomqvist
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Per Hall
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kamila Czene
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Astrid Irwanto
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianjun Liu
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nazneen Rahman
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clare Turnbull
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
Alison M. Dunning
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Pharoah
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Quinten Waisfisz
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanne Meijers-Heijboer
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andre G. Uitterlinden
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne; 32Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, Australia; 33Norway Cancer Registry, Norway; Departments of 34Public Health and Primary Care and 35Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge; 36Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine; 37Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 38Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 39Centre National de Genotypage, Evry; 40Fondation Jean Dausset–CEPH, Paris, France; Departments of 41Obstetrics and Gynecology, 42Clinical Genetics, and 43Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; 44Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 45Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; 46Department of Clinical Genetics, VU University Medical Center, Division of Oncogenetics, Amsterdam; and 47Department of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernando Rivadeneira
1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix; 17Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, Arizona; 18Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 19Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg; 20Clinic of Gynaecology and Obstetrics, Division for Gynaecological Tumor-Genetics, Technische Universität München; 21Max Planck Institute of Psychiatry, Munich; 22Department of Obstetrics and Gynaecology, Division of Molecular Gynaeco-Oncology, 23PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne; 24Foundation for Quality and Efficiency in Health Care, Cologne; 25Department of Cancer Epidemiology/Clinical Cancer Registry; 26Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg; 27Department of Psychiatry, University of Mainz, Mainz, Germany; 28Samuel Lunenfeld Research Institute; 29Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; 30Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, Melbourne School of Population Health; 31Genetic Epidemiology Laboratory, Department of Pathology, U